公司问答丨汇宇制药：公司与阿斯利康已签署战略合作框架协议 不涉及具体药物研究合作内容

Core Viewpoint - The company has signed a strategic cooperation framework agreement with AstraZeneca, but it does not involve specific drug research collaboration and will not have a significant impact on the company's operations [1] Group 1 - The company confirmed the signing of a strategic cooperation framework agreement with AstraZeneca [1] - The agreement does not include specific drug research collaboration content [1] - The company stated that the matter does not meet disclosure standards, hence no announcement was made [1] Group 2 - The company anticipates future collaborations with AstraZeneca in drug research and other areas [1] - If future collaborations are expected to significantly impact the company's operations, the company will comply with regulatory requirements for timely information disclosure [1]